Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 18 member B1 (SLC18B1), also known as the Vesicular Polyamine Transporter (VPAT), is a critical component of the human polyamine transport system (PTS) (Hiasa et al., 2014). It is the human ortholog of the yeast HOL1 protein and belongs to the Major Facilitator Superfamily (MFS) of transporters (UniProt Q6NT16). SLC18B1 functions by sequestering polyamines—essential organic cations like putrescine, spermidine, and spermine—into intracellular vesicles, thereby regulating their cytoplasmic availability and overall cellular homeostasis (Abdulrahman et al., 2021). Because polyamines are vital for cell growth and survival, cancer cells frequently upregulate SLC18B1 and the broader PTS to meet their increased metabolic demands (Casero et al., 2018). This makes SLC18B1 a significant therapeutic target; inhibitors such as AMXT-1501 are currently being evaluated in clinical trials, often in combination with polyamine synthesis inhibitors like eflornithine (DFMO), to starve tumors of these essential nutrients (ClinicalTrials.gov, NCT03538886). Additionally, the transporter's high activity in malignant cells allows it to be exploited for the targeted delivery of polyamine-drug conjugates, which use the PTS as a Trojan horse to internalize cytotoxic agents (Palmer & Wallace, 2010).
Competitive inhibition of polyamine uptake and vesicular sequestration; targeted delivery of polyamine-conjugated cytotoxic agents
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 18 member B1 (SLC18B1) (SLC18B1).